NIH doesn't recommend ivermectin because its panel members have conflicting financial interests
• Natural News - Ethan HuffYou see, by allowing ivermectin to be used as an early treatment for Chinese Germs, NIH board members could lose money in their other investments. And since money is their god, your life must be sacrificed on the altar of "science."
